Pacira BioSciences Inc (STU:82P)
€ 22.8 -0.60 (-2.56%) Market Cap: 901.83 Mil Enterprise Value: 1.08 Bil PE Ratio: 220.08 PB Ratio: 1.59 GF Score: 75/100

Pacira Biosciences Inc at RBC Capital Markets Global Healthcare Conference Transcript

May 20, 2026 / 12:30PM GMT
Release Date Price: €19.7 (+3.14%)
Unidentified Participant

So, for our next group setting here, we have Pacira Biosciences, and it's our pleasure to have Shawn Cross, the Chief Financial Officer, joining us today. Thank you for attending. Yeah, you bet.

Questions & Answers

Unidentified Participant

So I wanted to start off, no surprise, with a number of questions on EXPAREL, the franchise, what's going on in the market. And maybe I could first start off with when you look at Q1 2026, we had volume growth of around 7%, revenue growth was around 5%, and I know we're just about to lap that third GPO. I think you've indicated sometime this summer.

Can you talk about that volume to revenue gap and how that may change as we enter the second half of the year and the implications for the company?

Shawn Cross
Pacira Biosciences Inc - Chief Financial Officer

Sure, absolutely. So this is, as you would imagine, it's a question we get frequently. And just a reminder and a step back over the past 18 months or so, to really take advantage of the spark of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot